New Texas Law Removes Barrier to Clinical Trials
(September 1, 2009) – Effective September 1, 2009, Texas joins 27 states that require health benefit plans to cover routine costs for patients enrolled in clinical trials such as those for cancer and other life threatening diseases. Routine costs are medically necessary health services, such as doctor visits, hospital stays, tests, and x-rays-- care that patients with health insurance coverage would receive as a covered benefit even if they were not in a clinical trial. The 81st Texas Legislature passed Senate Bill 39, and Governor Perry signed the bill on June 19, 2009. View the entire press release here.
TLSF on The Stupid Cancer Show- March 9, 2009
Join TLSF Project Director Deborah Vollmer Dahlke for a discussion of clinical trial participation research and plans for a Texas Clinical Trial Network on The Stupid Cancer Show March 9 2009 at 8 pm CT. Hosted by iy Founder, Matthew Zachary, The Stupid Cancer Show is a pioneering new interactive talk radio broadcast finally giving voice to more than 1 million young adults affected by cancer. Join them every Monday night at 9pm/6pm (ET/PT) as they poke a stick at stupid cancer and make it hip to be a survivor. It's free, it's fun and it's a mini social network because you can interact with other listeners in a live chatroom!
For more information and program topics see visit stupidcancershow.com
TLSF Participates in Virtual Living Room Online Discussion of National Healthcare Concerns
(December 29, 2008) – In response to President-Elect Obama's call for community discussion of health care concerns, TLSF Project Director Deborah Vollmer Dahlke participated in an online webinar discussion hosted by the Intercultural Cancer Council. This series of online discussions focused on cancer control topics identified as important by ICC members. Reports out from the discussion are being shared with the new Obama administration.
TLSF Receives Grant from Pharmaceutical Research and Manufacturers of America
(November 28, 2008) – The Pharmaceutical Research and Manufacturers of America (PhRMA) provided Texas Life Science Foundation a $20,000 seed grant to support research on cancer clinical trial participation in Texas. PhRMA represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives.